Project Grant HT94252310634
Award Date
7/15/23
Completion Date
7/14/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This federal Project Grant award for $1,558,192.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at The Leland Stanford Junior University to develop focused ultrasound-induced peripheral nerve blockade techniques to reduce the development of neuropathic pain and treat acute and chronic pain. The research aims to transform healthcare for military service members and the broader public by investigating innovative...
The Department of the Army Medical Command awarded a $774,196 Project Grant to the University of California, San Francisco through the Military Medical Research and Development program. The grant will fund research from July 2022 to July 2025 to discover prognostic biomarkers and drugs for neuropathic pain in chronic spinal cord injury using big data and machine learning approaches. The Military Medical Research and Development program aims to advance biomedical research that transforms military...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
This Project Grant award, valued at $399,729.00, was provided by the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project focused on the clinical effectiveness of nonopioid pain management approaches to improve outcomes among active-duty service members. The award was granted to the University of Illinois, which will conduct this research over a 2-year period from November 1,...
This $366,000 federal Project Grant award, titled "VALIDATION OF A NONOPIOID ANALGESIC PATHWAY IN HUMAN SENSORY GANGLIA AND SPINAL CORD," was issued on September 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award was granted to the University of Florida to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research will explore innovative...
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
Duke University was awarded a $1,444,257 project grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop new approaches for preventing chronic pain and neuroinflammation resulting from traumatic brain injury. Specifically, the grant supports investigation of neuroprotectin D1 and GPR37 signaling to transform treatment for service members...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
The Defense Health Agency awarded a $2,206,031 project grant to Rush University Medical Center to fund the PREVENTING THE DEVELOPMENT OF CHRONIC PAIN: TREATING PTSD AT ACUTE PAIN ONSET program. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Specifically, the grant will fund...
This federal Project Grant award from the Department of the Army Medical Command provides $1,417,500 to The Washington University for the period of August 15, 2021 through August 14, 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve health care for service members and the public. Specifically, the grant aims to develop and validate predictive models for transition from acute to persistent pain...